Avadel Pharmaceuticals Upcoming Investor Conference Participation
![Avadel Pharmaceuticals Upcoming Investor Conference Participation](https://investorshangout.com/images/blog/ihnews-Avadel%20Pharmaceuticals%20Upcoming%20Investor%20Conference%20Participation.jpg)
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, has announced that its management team will participate in several forthcoming investor conferences. These engagements represent an opportunity for the company to connect with investors and discuss its strategic vision and innovative solutions.
Details of the Upcoming Conferences
The upcoming investor conferences include:
- 2024 Wells Fargo Healthcare Conference: A fireside chat is scheduled for September 4 at 3:45 p.m. ET.
- Morgan Stanley 22nd Annual Global Healthcare Conference: A fireside chat will take place on September 6 at 10:00 a.m. ET.
- H.C. Wainwright 25th Annual Global Investment Conference: A fireside chat is set for September 11 at 11:30 a.m. ET.
These conferences provide a platform for Avadel's leadership to share insights and updates regarding the company's progress and future direction.
Live Webcasts and Recordings
Avadel Pharmaceuticals plans to offer live webcasts of these events as well as archived recordings. All presentations will be available for viewing on Avadel’s Investor Relations website for 90 days following each conference. Stakeholders and interested parties are encouraged to tune in, as these discussions will delve into the company’s innovations and growth strategies.
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc specializes in developing transformative medicines. The company is dedicated to creating innovative solutions that address the numerous challenges patients encounter with existing treatment options. Avadel's commercial product, LUMRYZ™, is notable for being the first and only once-at-bedtime oxybate approved by the U.S. Food and Drug Administration (FDA) for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults suffering from narcolepsy. This significant achievement demonstrates Avadel's commitment to improving patient outcomes through innovative pharmaceutical developments.
Commitment to Innovation
Through its research and development efforts, Avadel Pharmaceuticals is focused on formulating medications that emphasize both efficacy and patient adherence. The company's continuous investment in innovation aims to fulfill unmet medical needs and enhance the quality of life for patients.
Contact Information
For any inquiries or further information, investors and media representatives can reach out to the following contacts:
Investor Contact
Courtney Mogerley
Precision AQ
Email: Courtney.Mogerley@precisionAQ.com
Phone: (212) 698-8687
Media Contact
Lesley Stanley
Real Chemistry
Email: lestanley@realchemistry.com
Phone: (609) 273-3162
Frequently Asked Questions
What is Avadel Pharmaceuticals focusing on in its upcoming conferences?
Avadel Pharmaceuticals aims to present its strategic vision and innovative solutions, particularly focusing on its transformative medicines.
When will Avadel participate in the Wells Fargo Healthcare Conference?
The company is scheduled to participate in the Wells Fargo Healthcare Conference on September 4 at 3:45 p.m. ET.
Where can I watch the webcasts of the conferences?
The live webcasts and archived recordings will be available on Avadel's Investor Relations website for 90 days after each conference.
What is LUMRYZ™?
LUMRYZ™ is Avadel's commercial product, recognized as the first and only once-at-bedtime oxybate approved by the FDA for treating narcolepsy-related symptoms.
How can I contact Avadel Pharmaceuticals for investor relations?
For investor inquiries, you can contact Courtney Mogerley via email at Courtney.Mogerley@precisionAQ.com or by phone at (212) 698-8687.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- NewtekOne, Inc. CEO Barry Sloane to Attend Key Conference
- AUGA group, AB Investor Conference Webinar Details
- Pasithea Therapeutics to Present at Investment Conference
- Interlink Electronics to Present at Annual Gateway Conference
- GitLab CFO Brian Robins to Speak at Piper Sandler Conference
- Editas Medicine to Present at Major Investor Conferences
- Kura Sushi USA's Upcoming Investor Conferences for Engagement
- NORD Holding Selects Intapp DealCloud for Investor Relations
- HOOKIPA Pharma Engages Investors at Global Conference
- Lantheus to Showcase Innovations at Global Healthcare Conference